[1]Day CP.Nonalcoholic steatohepatitis (NASH) :where are we nowand where are we going?[J].Gut, 2002, 50∶585-588.
|
[2]Marchesini G, Forlani G.NASH:from liver diseases to metabolicdisorders and back to clinical hepatology[J].Hepatology, 2002, 35∶497-499.
|
[3]范建高, 丁晓东, 曾说.非酒精性脂肪性肝炎:美国肝脏病学会专题研讨会纪要[J].肝脏, 2003, 8 (2) ∶59-61.
|
[4]朱曼, 王睿, 张永清, 等.大鼠肝微粒体细胞色素P450酶系检测方法学研究[J].中国临床药理学与治疗学, 2004, 9 (5) ∶500-503.
|
[5]尤鹏.非酒精性脂肪肝炎发病机制的研究进展[J].中国医药导刊, 2003, 5 (2) ∶97-99.
|
[6]Rashid A, Wu T, Huang C, et al.Mitochondrial proteins that regu-late apoptosis and necrosis are induced in mouse fatty liver[J].Hep-atology, 1999, 29∶1131-1138.
|
[7]Bugianesi E, Manzini P, D'Antico S, et al.Relative contribution ofiron burden, HFE mutations, and insulin resistance to fibrosis innonalcoholic fatty liver[J].Hepatology, 2004, 39∶179-187.
|
[8]Rao MS, Reddy JK.Peroxisomal beta-oxidation and steatohepatitis[J].Semin Liver Dis, 2001, 21 (1) ∶43-55.
|
[1] | Enrui XIA, Gege TIAN, Suyan ZHANG, Shunzhen ZHANG. Effect of Quzhi Ruangan prescription on the farnesoid X receptor-fibroblast growth factor 19 pathway in rats with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2022, 38(5): 1069-1074. doi: 10.3969/j.issn.1001-5256.2022.05.018 |
[2] | Heng ZHU, Weizong KONG, Guiqun HUANG, Yu BAI, Yingchun WANG. Influence of histone deacetylase 1 on insulin resistance in a cell model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(9): 2010-2015. doi: 10.3969/j.issn.1001-5256.2022.09.013 |
[3] | Weiyu CHEN, Faming SHU, Han WANG, Yanggang CAO, Jin HU, Dewen MAO. Role of the cytochrome P450 family in metabolic-associated liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(9): 2182-2187. doi: 10.3969/j.issn.1001-5256.2022.09.045 |
[4] | Wang QiaoLing, Zou ZhengSheng. Association between cytochrome P450 gene polymorphism and drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(5): 1150-1153. doi: 10.3969/j.issn.1001-5256.2020.05.045 |
[5] | Dou AiHua, Hui Wei, Liu Mei, Wei LinLin, Zhao Juan, Ma ChunHua, Zheng XiaoQin, Xiong Fang, Yang Xue, Zhang Mei, Xu Bin. Association between rs2943650 mutation and insulin resistance in patients with chronic liver disease and type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2018, 34(11): 2379-2382. doi: 10.3969/j.issn.1001-5256.2018.11.022 |
[6] | Liu DaJi, Chen QingFeng. Pathogenesis of insulin resistance and its impact on antiviral therapy in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2017, 33(6): 1152-1155. doi: 10.3969/j.issn.1001-5256.2017.06.029 |
[7] | Ding ZhiYong, Bu Le, Lu HongYan, Rao ZhengXuan. Correlation of liver fat content with serum vitamin A level and insulin resistance in patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2361-2365. doi: 10.3969/j.issn.1001-5256.2017.12.021 |
[8] | Zhang QiuNan, Xiao Ying, Miao RuiXin, Zhang YaQing, Zhu Ying. Changes in intestinal flora in nonalcoholic fatty liver disease: their correlation with insulin resistance index,tumor necrosis factor- α,and interleukin- 6[J]. Journal of Clinical Hepatology, 2015, 31(7): 1078-1081. doi: 10.3969/j.issn.1001-5256.2015.07.019 |
[9] | Ma LiNa, Feng Ming, Zhou YingZhi, Ma Jia, Hao Peng. The relationship between nonalcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2010, 26(2): 173-174+177. |
[11] | Yu XiaoHu, Zhu JinShui, Gu GuoMei, Shi JianPing. Clinical effect of oxymatrine combined with metformin on insulin resistance and serum TNF-α in patients with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(3): 195-196. |
[12] | Zhang FenMing, Gao SuQin, Kong DeZhi. Relationship between nonalcoholic fatty liver disease and insulin resistance in hypertensive patients[J]. Journal of Clinical Hepatology, 2007, 23(4): 277-279. |
[13] | Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361. |
[15] | Liang Bing, Chen Xi, Liu ShuangYan, Wang YiGe, An QiuHong. The relationship between non-alcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2006, 22(3): 213-214. |
[16] | Chen ZuSen, Liang Xing. Changes of serum lipid in patients with hepatocirrhosis[J]. Journal of Clinical Hepatology, 2005, 21(1): 34-35. |
[17] | Dai Lin, Deng Bin, Li AiPing, Yu HongBo, Bai Cheng, Lu ShengMing. Experimental study on the pathogenesis of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2004, 20(5): 285-286. |
[18] | Huang JiLiang, Wu Fang, Zhang XinRan, Wang DongHua, Zhao RuiZhi. Relationship between tumor necrosis factor-α and lnsulin resistance in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2002, 18(3): 166-167. |
[19] | Ma YingJie, Fang LiFeng, Feng SuPing, Jia KeLi, Fu ZhenLie. Obesity and insulin resistance in nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2002, 18(4): 241-242. |